A new trading day began on Tuesday, with Novartis AG ADR (NYSE: NVS) stock price down -1.42% from the previous day of trading, before settling in for the closing price of $118.09. NVS’s price has ranged from $96.06 to $120.92 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 1.16%. Meanwhile, its annual earnings per share averaged 10.04%. With a float of $1.90 billion, this company’s outstanding shares have now reached $1.96 billion.
The extent of productivity of a business whose workforce counts for 75883 workers is very important to gauge. In terms of profitability, gross margin is 75.4%, operating margin of 29.79%, and the pretax margin is 28.22%.
Novartis AG ADR (NVS) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – General Industry. The insider ownership of Novartis AG ADR is 0.00%, while institutional ownership is 7.34%. The most recent insider transaction that took place on May 23 ’25, was worth 1,690,181. Before that another transaction happened on Apr 30 ’25, when Company’s Officer proposed sale 1,212 for $113.28, making the entire transaction worth $137,297.
Novartis AG ADR (NVS) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 10.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.66% during the next five years compared to 13.99% growth over the previous five years of trading.
Novartis AG ADR (NYSE: NVS) Trading Performance Indicators
Here are Novartis AG ADR’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.61. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.27. Likewise, its price to free cash flow for the trailing twelve months is 12.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.39, a number that is poised to hit 2.31 in the next quarter and is forecasted to reach 8.92 in one year’s time.
Technical Analysis of Novartis AG ADR (NVS)
The latest stats from [Novartis AG ADR, NVS] show that its last 5-days average volume of 1.24 million was inferior to 2.08 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 38.18%. Additionally, its Average True Range was 1.73.
During the past 100 days, Novartis AG ADR’s (NVS) raw stochastic average was set at 80.56%, which indicates a significant increase from 54.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 18.65% in the past 14 days, which was lower than the 24.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $112.04, while its 200-day Moving Average is $109.11. Now, the first resistance to watch is $117.41. This is followed by the second major resistance level at $118.40. The third major resistance level sits at $118.98. If the price goes on to break the first support level at $115.84, it is likely to go to the next support level at $115.26. The third support level lies at $114.27 if the price breaches the second support level.
Novartis AG ADR (NYSE: NVS) Key Stats
With a market capitalization of 220.90 billion, the company has a total of 2,112,422K Shares Outstanding. Currently, annual sales are 51,722 M while annual income is 11,941 M. The company’s previous quarter sales were 13,620 M while its latest quarter income was 3,606 M.
